Sarcoidosis Board decisions

The Board has dismissed the appeal for service connection of multiple conditions due to the appellant's death.

The Board has remanded the Veteran's claims for service connection for sarcoidosis and cause of death due to in-service exposure to toxic chemicals or mustard gas. The remand requires a TERA medical opinion regarding these claims.

The Board has dismissed the claim of service connection for a right shoulder disorder as it was previously addressed in another decision under the AMA appeals process. The claim for an initial higher rating for lung sarcoidosis disease is remanded due to duty to assist errors.

The Veteran's sarcoidosis is rated at a 30 percent rating, requiring intermittent corticosteroids.

The Veteran's current sleep apnea is due to his service-connected sarcoidosis and residuals of bladder cancer, and the Board has granted service connection for this condition.

The Veteran's left lower extremity scar is granted a 10% rating effective August 10, 2016. Service connection for pulmonary sarcoidosis is also granted.

The Board denied service connection for a respiratory condition, including fibrotic lung changes, bronchiectasis, and COPD, as secondary to sarcoidosis. The evidence did not support a finding that the Veteran's current conditions were related to his in-service treatment or service.

The Board has granted service connection for asthma, claimed as sarcoidosis, effective prior to August 9, 2023. Sarcoidosis was not found and the Veteran's respiratory issues are attributed to asthma.

The Board denied service connection for sarcoidosis, finding that the Veteran's condition did not begin during active duty or within one year of separation and was not related to any in-service injury, event, or disease.

The Board has remanded the claims for diabetes, RLE tarsal tunnel syndrome, heart condition, residuals of stroke, sarcoidosis, and migraine headaches due to inadequate opinions in previous VA medical opinions.

The Veteran's service-connected disabilities, including a lumbar disorder, migraines, ovarian cysts, sarcoidosis, right and left lower extremity radiculopathies, have rendered her unable to secure or follow substantially gainful employment prior to January 28, 2009. The Board finds that referral to the Director of Compensation Service is necessary for consideration of an extraschedular TDIU.

The Veteran's sarcoidosis disability is rated at 60 percent prior to August 20, 2022. The Board denied an increased rating as the evidence did not meet the criteria for a higher rating under DCs 6600 or 6846.,Service connection was denied for secondary eye disability, muscle weakness, hypertension, and headaches due to sarcoidosis.

The Veteran's sarcoidosis is rated based on bronchitis, but he asserts the severity of his rating does not accurately reflect the severity of his symptomology. The Board finds that additional VA examination and medical opinion are needed to determine if an increased rating is warranted.

The Veteran's initial separate and compensable disability rating of 20 percent for bilateral dry eye syndrome has been granted. The remaining issues have been remanded due to insufficient evidence or need for further examination.

The Board has remanded the case for a new VA examination to determine if the Veteran's pulmonary sarcoidosis was aggravated by his active duty service and whether it existed prior to service.

The Board has decided that the Veteran's claims for service connection for blurred vision and sarcoidosis need to be remanded due to incomplete development of the record.

The Veteran's PTSD symptoms have more nearly approximated the criteria for occupational and social impairment with deficiencies in most areas since June 5, 2020.,From June 17, 2019, multiple service-connected disabilities rendered the Veteran unable to secure and follow a substantially gainful occupation.

The Board has determined that the Veteran's claims for service connection related to sarcoidosis, headaches, ectopic pregnancy and its residuals, and left big toe fracture require further development due to pre-decisional duty to assist errors.

The Veteran's appeal is remanded for additional examinations to address the severity of his bilateral pes planus, pulmonary and cutaneous sarcoidosis, degenerative joint disease left knee with meniscal tear, and degenerative joint disease right knee with meniscal tear. The issues on appeal are related to service connection.

The Veteran's claim for a higher rating for right knee arthritis with meniscal tear prior to January 9, 2019 and after March 1, 2019 is remanded. The Veteran's claim for a compensable rating for left knee replacement scar is also remanded. The Veteran's claim for a rating in excess of 30 percent for left knee arthritis (status post replacement) is also remanded.,The Veteran seeks service connection for diabetes mellitus type II, which the RO denied as not shown to be related to service. The issue is being remanded due to new and material evidence having been received.,The Veteran's claim for pulmonary sarcoidosis is being remanded due to possible exposure to asbestos and contaminated water at Camp Lejeune.,The Veteran seeks service connection for a right elbow disability, which the RO denied as not related to service. The issue is being remanded due to possible exposure to hazardous chemicals in service.,The Veteran seeks service connection for a right wrist disability, which the RO denied as not related to service. The issue is being remanded due to possible exposure to hazardous chemicals in service.